Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Post by FredTheVoiceon Oct 09, 2018 7:53am

117 Views

Post# 28765037

Up 9% since last thursday

We will see in a couple of weeks from now, but the reality is that we are up 9% (stock) since the good 3rd quarter result.

And for the analyst KNOWING something that we dont know.........well well........we should stick with facts: good trend in sales for TROGARZO; news coming from FDA in november; company that is sitting in the profit zone; and TANGUAY that we can have confidence in, and that is sitting on a load of money to buy a new drug !

Thao.......what do you think about that ? Analysts will ajust very soon there watch and there glasses...

FTV.

Bullboard Posts

From now on, dynaCERT instead of Bitcoin or NVIDIA?